Vivos Therapeutics DNA oral device gets FDA nod for obstructive sleep apnea

Raghuram Kadari- January 6, 2023 0

Vivos Therapeutics has secured the US Food and Drug Administration (FDA) 510(k) clearance for its DNA oral device indicated for obstructive sleep apnea (OSA) treatment. ... Read More

Excessive usage of smartphones can adversely affect your child's health

pharmanewsdaily- November 23, 2016 0

Now a days, majority of children are addicted to the usage of smart phones for playing games or watching videos even during bed time. In ... Read More